Results 251 to 260 of about 370,662 (286)

Access to National Cancer Institute (NCI)–designated cancer centers among Native American patients with cancer.

Journal of Clinical Oncology, 2023
e18646 Background: Native Americans (NA) have some of the highest mortality rates from cancer in the US. Despite that, they face significant geographic barriers to access to cancer care. However, little study addresses disparities in accessibility in NA population.
Haoran Li, Kamal Kant Sahu, Georges Gebrael, Vinay Mathew Thomas, Nishita Tripathi, Nicolas Sayegh, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami   +8 more
openaire   +1 more source

Attendance at National Cancer Institute Cancer Centers (NCI-CC) by older adults with myeloma.

Journal of Clinical Oncology, 2017
e18020 Background: Older adults with myeloma (MM) have poorer survival than younger patients. NCI-CC attendance is associated with superior outcomes in many cancers. Studies show that older adults are reluctant to be treated in university settings and are more likely to be treated in the community setting.
Tanya Marya Wildes, Mark A Fiala
  +4 more sources

Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).

Journal of Clinical Oncology, 2021
6565 Background: Patients (pts) with cancer are at increased risk of SARS-CoV-2 infection and severe COVID-19 disease. Longitudinal follow-up is needed to characterize the severity, sequelae and outcomes in pts with cancer who develop COVID-19. Methods: NCCAPS is a prospective, longitudinal study (NCT04387656) aiming to accrue 2,000 pts with cancer ...
Larissa A. Korde, Ana F. Best, Sacha Gnjatic, Andrea M. Denicoff, Grace E. Mishkin, Melissa Bowman, Lyndsay Harris, Ann M. Geiger, Worta J. McCaskill-Stevens, Stephen J. Chanock, Patricia Spears, Lawrence Rubinstein, Nicholas M. Mark, Jeremy Lyle Warner, Carmen Joseph Allegra, Adam J. Esbenshade, Michael V. Knopp, James H. Doroshow, Brian I. Rini   +18 more
openaire   +1 more source

National Cancer Institute (NCI) 1-day method

2019
The National Cancer Institute (NCI) 1-day method, a new statistical method, uses single-day dietary intake data and an external estimate of within- and between-person variation to estimate population distributions of usual intake of nearly-daily consumed foods and nutrients.
Arnold, Charles D, Dodd, Kevin W., Engle-Stone, Reina, Luo, Hanqi   +3 more
openaire   +1 more source

Nutrition Education Services Described on National Cancer Institute (NCI)-Designated Cancer Center Websites

Journal of Cancer Education, 2017
For women diagnosed with breast cancer, healthy weight and enhanced nutrition may improve outcomes. The goal of this study is to examine the nutrition education services available on National Cancer Institute (NCI)-Designated Cancer Centers' websites.
Rani, Polak, Julia M, Reilly, Lauren E, Elson, Vanessa C, Gallegos-Kearin, Saurabha, Bhatnagar, Jeffery C, Schneider, Julie K, Silver   +6 more
openaire   +2 more sources

NCI mpact: National Cancer Institute molecular profiling-based assignment of cancer therapy.

Journal of Clinical Oncology, 2014
TPS2642 Background: There is growing interest in matching targeted agents to genetic aberrations found in tumors of patients in early phase trials.
Shivaani Kummar, Mickey Williams, Chih-Jian Lih, Alice P. Chen, Larry Rubinstein, Ramya Antony, Eric Polley, Yingdong Zhao, Barbara A. Conley, Richard Simon, James H. Doroshow   +10 more
openaire   +1 more source

Management of thymic epithelial tumors (TETs) at the National Cancer Institute (NCI).

Journal of Clinical Oncology, 2011
e17511 Background: TETs are very rare anterior mediastinal tumors. Methods: We performed a retrospective review of patients (pts.) with TETs presenting to the NCI for enrollment in ongoing clinical trials, standard-of-care therapy or a second opinion. Results: Seventy-three pts.
A. Rajan, R. J. Kelly, A. Lopez-Chavez, C. A. Carter, E. Szabo, B. Scepura, M. J. (. Manu, A. W. Berman, G. Giaccone   +8 more
openaire   +1 more source

Graphical representations of patient tolerability data: Recommendations from the National Cancer Institute (NCI) Cancer Moonshot Standardization Working Group.

Journal of Clinical Oncology, 2021
e18612 Background: Effective communication of treatment tolerability data is essential for clinical decision making and improved patient outcomes, yet standardized approaches to the analysis and visualization of tolerability data in cancer clinical trials are currently limited.
Gillian Gresham, Gina L. Mazza, Blake Langlais, Bellinda King-Kallimanis, Lauren J. Rogak   +4 more
openaire   +1 more source

A survey of cancer support groups provided by national cancer institute (NCI) clinical and comprehensive centers

Psycho-Oncology, 1993
AbstractThe 42 National Cancer Institute Clinical and Comprehensive Cancer Centers were surveyed about their group support programs. All responding centers (81%) offered group support programs, an average of 3.5 groups per center. There were an average of 6.0 members per group. About an equal number of groups were composed of patients or family members
Burton A. Presberg, James L. Levenson
openaire   +1 more source